Rémission du diabète de type 2 : Une vue d'ensemble
Résumé
Dans ma pratique, l’une des questions les plus fréquentes que mes patients atteints de diabète de type 2 (DT2) me posent est celle-ci : « Comment puis-je me débarrasser de cette maladie? »
Le principal sujet de discussion des praticiens concernant le DT2 est la nature chronique et irréversible de cette maladie. Toutefois, depuis peu, le nombre croissant de données probantes disponibles fait naître de nouveaux espoirs quant à la rémission du diabète.
Références
International Diabetes Federation. IDF diabetes atlas. 10th edition. Brussels: International Diabetes Federation. 2021. [accessed 2022 May 22]. https://www.diabetesatlas.org.
Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544.
Spencer Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don’t talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage. JAMA Intern Med 2016;176(8):1053-1054.
Canadian Diabetes Cost Model. Ottawa: Diabetes Canada; 2016.
MacKay D, Chan C, Dasgupta K, Dominy C, Gagner M, Jin S, et al. Diabetes Canada Clinical Practice Guidelines Steering Committee: Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group. Can J Diabetes. 2022 Dec;46(8):753-761.
UKPDS Group. U.K. Prospective Diabetes Study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 1995;44(11):1249-1258.
Wysham C, Shubrook J. Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgrad Med 2020;132(8):676-686.
Albaugh VL, Axelrod C, Belmont KP, Kirwan JP. Physiology reconfigured: how does bariatric surgery lead to diabetes remission? Endocrinol Metab Clin North Am. 2023 Mar;52(1):49-64.
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356.
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster randomised trial. Lancet Diabetes Endocrinol 2019;7(5):344e55.
Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care. 2001 Sep;24(9):1522-1527.
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020 Aug 4;192(31):E875-E891.
Publié
Comment citer
Numéro
Rubrique
Licence
© Canadian Diabetes & Endocrinology Today 2023
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
